Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Teva Pharmaceutical Sp Adr (TEVA US)
Watchlist
105
Analysis
Health Care
•
Israel
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Health and Happiness
•
27 Jun 2017 17:03
Health & Happiness: Not that Healthy After All and May Lead to Unhappy Shareholders?
Post the disclosure of the agreement that Swisse made with a JV that is owned by Procter & Gamble Co/The (PG US) and Teva Pharmaceutical Sp Adr...
Henry Soediarko
Follow
548 Views
Share
bullish
•
Mesoblast Ltd
•
11 Apr 2017 09:07
Lead Heart Trial Beats Faster for Mesoblast; Interim Analysis Encouraging
We are raising our fair value estimate to AUD 2.80 per share from AUD 2.30 for no-moat Mesoblast Ltd (MSB AU), following the encouraging interim...
Morningstar, Inc.
238 Views
Share
bearish
•
Aurobindo Pharma
•
17 Feb 2017 10:10
A Storm Will Follow the Lull
Newsflow around the US and state governments' antitrust investigations of the generic drug industry has been quiet since mid-December. Some lull is...
Kemp Dolliver, CFA
846 Views
Share
bearish
•
Mylan NV
•
15 Dec 2016 21:35
Indictments Starting to Appear
The US Department of Justice (DOJ) filed charges (attached) against two former senior executives of Heritage Pharmaceuticals, a subsidiary of Pune,...
Kemp Dolliver, CFA
426 Views
Share
bullish
•
Sun Pharma
•
05 Dec 2016 12:02
'Cures Act', Halol Plant FDA Inspection and a Russian Acquisition.
We continue to be bullish on Sun Pharmaceutical Indus (SUNP IN) after the recent news of progress in passing the '21st century Cures Act' in the...
Dr. Bhavneesh Sharma, MD, MBA
454 Views
Share
First
Previous
17
18
19
20
21
22
23
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x